Skip to Content
Merck

717916

Chloroform solution

suitable for NMR (reference standard), 5% in acetone-d6 (99.9 atom % D), chromium(III) acetylacetonate 0.2 %

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

NACRES:
NA.11
PubChem Substance ID:
UNSPSC Code:
12190000
MDL number:
Form:
solution
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


form

solution

Quality Level

composition

chromium(III) acetylacetonate, 0.2%

concentration

5% in acetone-d6 (99.9 atom % D)

technique(s)

NMR: suitable

NMR tube size

5 mm × 7 in. , 5 mm × 8 in.

suitability

suitable for NMR (reference standard)

SMILES string

ClC(Cl)Cl

InChI

1S/CHCl3/c2-1(3)4/h1H

InChI key

HEDRZPFGACZZDS-UHFFFAOYSA-N

Features and Benefits

1H line shape

Preparation Note

5 mm O.D. tube contains 0.700 mL.


Still not finding the right product?

Explore all of our products under Chloroform solution


signalword

Danger

Hazard Classifications

Carc. 2 - Eye Irrit. 2 - Flam. Liq. 2 - Repr. 2 - STOT RE 2 Oral - STOT SE 3

target_organs

Central nervous system, Liver,Kidney

supp_hazards

Storage Class

3 - Flammable liquids

wgk

WGK 3

flash_point_f

32.0 °F - closed cup

flash_point_c

0 °C - closed cup


Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

67-66-3

CAS No.


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Matteo Serino et al.
PloS one, 6(6), e21184-e21184 (2011-06-24)
Daily variations in lipid concentrations in both gut lumen and blood are detected by specific sensors located in the gastrointestinal tract and in specialized central areas. Deregulation of the lipid sensors could be partly involved in the dysfunction of glucose